ANTICANCER EFFECT OF TAMOXIFEN IN ORAL CANCER CELL
![]() |
Jung, Jae-Hwa
(Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University)
Yun, Pil-Young (Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University) Myoung, Hoon (Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University) Shin, Jae-Il (Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University) Lee, Jong-Ho (Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University) Kim, Myung-Jin (Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University) |
1 | Hyder SM, Stancel GM. In vitro interaction of uterine estrogen receptor with the estrogen response element present in the 3'-flanking region of the murine c-fos protooncogene. J Steroid Biochem Mol Biol. 1994 Jan;48(1):69-79. |
2 | Cowley SM, Parker MG. A comparison of transcriptional activation by ER alpha and ER beta. J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):165-75. |
3 | Altan N, Chen Y, Schindler M, Simon SM. Tamoxifen inhibits acidification in cells independent of the estrogen receptor. Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4432-7. |
4 | Levine AC, Liu XH, Greenberg PD, Eliashvili M, Schiff JD, Aaronson SA, Holland JF, Kirschenbaum A. Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts. Endocrinology. 1998 Nov;139(11):4672-8. |
5 | Hoelting T, Siperstein AE, Duh QY, Clark OH. Tamoxifen inhibits growth, migration, and invasion of human follicular and papillary thyroid cancer cells in vitro and in vivo. J Clin Endocrinol Metab. 1995 Jan;80(1):308-13. |
6 | Shadaba A, Gaze MN, Grant HR. The response of adenoid cystic carcinoma to tamoxifen. J Laryngol Otol. 1997 Dec;111(12):1186-9. |
7 | Shick PC, Riordan GP, Foss RD. Estrogen and progesterone receptors in salivary gland adenoid cystic carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Oct;80(4):440-4. |
8 | Wada T, Nishiyama K, Maeda M, Hara S, Tanaka N, Yasutomi M, Kurita T. Combined chemoendocrine treatment with tegafur and tamoxifen for advanced renal cell carcinoma. Anticancer Res. 1995 Jul-Aug;15(4):1581-4. |
9 | Santin AD, Hermonat PL, Ravaggi A, Cannon MJ, Pecorelli S, Parham GP. Secretion of vascular endothelial growth factor in ovarian cancer. Eur J Gynaecol Oncol. 1999;20(3):177-81. PUBMED |
10 | Engstrom PF, Levin B, Moertel CG, Schutt A. A phase II trial of tamoxifen in hepatocellular carcinoma. Cancer. 1990 Jun 15;65(12):2641-3. |
11 | Schmitt FC, Zelandi Filho C, Bacchi MM, Castilho ED, Bacchi CE. Adenoid cystic carcinoma of trachea metastatic to the placenta. Hum Pathol. 1989 Feb;20(2):193-5. |
12 | Hyder SM, Nawaz Z, Chiappetta C, Stancel GM. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res. 2000 Jun 15;60(12):3183-90. |
13 | Mullauer L, Grasl-Kraupp B, Bursch W, Schulte-Hermann R. Transforming growth factor beta 1-induced cell death in preneoplastic foci of rat liver and sensitization by the antiestrogen tamoxifen. Hepatology. 1996 Apr;23(4):840-7. |
14 | Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995 May;146(5):1029-39. Review. |
15 | Farinati F, De Maria N, Fornasiero A, Salvagnini M, Fagiuoli S, Chiaramonte M, Naccarato R. Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma. Dig Dis Sci. 1992 May;37(5):659-62. |
16 | Werner A, Bender E, Mahaffey W, McKeating J, Marrangoni A, Katoh A. Inhibition of experimental liver metastasis by combined treatment with tamoxifen and interferon. Anticancer Drugs. 1996 May;7(3):307-11. |
17 | Klein-Hitpass L, Ryffel GU, Heitlinger E, Cato AC. A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor. Nucleic Acids Res. 1988 Jan 25;16(2):647-63. |
18 | Rak J, Filmus J, Kerbel RS. Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis. Eur J Cancer. 1996 Dec;32A(14):2438-50. Review. |
19 | Aldous WK, Marean AJ, DeHart MJ, Matej LA, Moore KH. Effects of tamoxifen on telomerase activity in breast carcinoma cell lines. Cancer. 1999 Apr 1;85(7):1523-9. |
20 | Auerbach W, Auerbach R.Angiogenesis inhibition: a review. Pharmacol Ther. 1994 Sep;63(3):265-311. Review. |
21 | Charlier C, Chariot A, Antoine N, Merville MP, Gielen J, Castronovo V. Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells. Biochem Pharmacol. 1995 Jan 31;49(3):351-8. |
22 | Shen F, Xue X, Weber G. Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells. Anticancer Res. 1999 May-Jun;19(3A):1657-62. |
23 | Charlier C, Chariot A, Antoine N, Merville MP, Gielen J, Castronovo V. Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells. Biochem Pharmacol. 1995 Jan 31;49(3):351-8. |
24 | Ro JY, Silva EG, Gallager HS. Adenoid cystic carcinoma of the breast. Hum Pathol. 1987 Dec;18(12):1276-81. Review. |
25 | Anolik JH, Klinge CM, Brolly CL, Bambara RA, Hilf R. Stability of the ligand-estrogen receptor interaction depends on estrogen response element flanking sequences and cellular factors. J Steroid Biochem Mol Biol. 1996 Dec;59(5-6):413-29. |
26 | Tsai LC, Hung MW, Yuan CC, Chao PL, Jiang SY, Chang GG, Chang TC. Effects of tamoxifen and retinoic acid on cell growth and c-myc gene expression in human breast and cervical cancer cells. Anticancer Res. 1997 Nov-Dec;17(6D):4557-62. |
27 | Wiseman H. Tamoxifen: new membrane-mediated mechanisms of action and therapeutic advances. Trends Pharmacol Sci. 1994 Mar;15(3):83-9. Review. |
28 | Fan CY, Wang J, Barnes EL. Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature. Am J Surg Pathol. 2000 Apr;24(4):579-86. DOI ScienceOn |
29 | Perry RR, Kang Y, Greaves B. Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells. Ann Surg Oncol. 1995 May;2(3):238-45. |
30 | Hyder SM, Stancel GM, Nawaz Z, McDonnell DP, Loose-Mitchell DS. Identification of an estrogen response element in the 3'-flanking region of the murine c-fos protooncogene. J Biol Chem. 1992 Sep 5;267(25):18047-54. |
![]() |